Inactivation of PTEN promotes aberrant sterol regulatory element-binding proteins (SREBP)-dependent lipogenesis, thus driving metastatic progression in a mouse prostate tumor model [114]. The gene discussed is PTEN; the disease is prostate neoplasm.